The Rheumatology Network gout clinical focus page provides information on the latest gout news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for gout drugs.
August 18, 2022
“These observations suggest that the often-observed epidemiologic correlation between low serum urate and adverse health outcomes may be confounded."
August 15, 2022
Despite gout being largely associated with White men, new data suggest gout and hyperuricemia impart a larger burden on other demographic groups, including Black men, Black women, and White women.
August 11, 2022
"COVID-19 vaccines are effective against severity of SARS-COV-2 infection, but there has been a concern regarding their effect on the risk of flares in patients with gout, which are associated with health-related quality of life, healthcare resource utilization, and work productivity."
July 13, 2022
John K. Botson MD, RPh, CCD, weighs in on the recent FDA approval of pegloticase injection plus methotrexate for the treatment of uncontrolled gout.
July 08, 2022
The decision was based on results from the MIRROR trial, which evaluated the concomitant use of pegloticase with methotrexate.
July 07, 2022
In the prospective, open-labeled trial, patients were randomly assigned to receive either low-dose benzbromarone or low-dose febuxostat for 12 weeks.
June 29, 2022
The approval and implementation of new drugs can vastly improve quality of life and reduce signs and symptoms of disease burden in patients with rheumatic and dermatologic diseases.
June 28, 2022
Take a few minutes to discover Rheumatology Network's most-viewed EULAR 2022 coverage.
June 25, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending June 25, 2022.
June 22, 2022
Investigators identified novel biomarkers of incident gout and replicated novel metabolomic biomarkers of gout, including plasma levels of glycoprotein acetyls.